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Abstract
Sterile-alpha-motif (SAM) domains are common protein interaction motifs observed in organisms as diverse as yeast and
human. They play a role in protein homo- and hetero-interactions in processes ranging from signal transduction to RNA
binding. In addition, mutations in SAM domain and SAM-mediated oligomers have been linked to several diseases. To date,
the observation of heterogeneous SAM-mediated oligomers in vivo has been elusive, which represents a common challenge
in dissecting cellular biochemistry in live-cell systems. In this study, we report the oligomerization and binding
stoichiometry of high-order, multi-component complexes of (SAM) domain proteins Ste11 and Ste50 in live yeast cells using
fluorescence fluctuation methods. Fluorescence cross-correlation spectroscopy (FCCS) and 1-dimensional photon counting
histogram (1dPCH) confirm the SAM-mediated interaction and oligomerization of Ste11 and Ste50. Two-dimensional PCH
(2dPCH), with endogenously expressed proteins tagged with GFP or mCherry, uniquely indicates that Ste11 and Ste50 form
a heterogeneous complex in the yeast cytosol comprised of a dimer of Ste11 and a monomer of Ste50. In addition, Ste50
also exists as a high order oligomer that does not interact with Ste11, and the size of this oligomer decreases in response to
signals that activate the MAP kinase cascade. Surprisingly, a SAM domain mutant of Ste50 disrupted not only the Ste50
oligomers but also Ste11 dimerization. These results establish an in vivo model of Ste50 and Ste11 homo- and hetero-
oligomerization and highlight the usefulness of 2dPCH for quantitative dissection of complex molecular interactions in
genetic model organisms such as yeast.
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Introduction
Determining the state of protein complex formation is critical
for understanding many signaling and structural pathways. Often
protein interactions are mediated through conserved domains,
such as the well-studied Src homology 3 (SH3) and PDZ domains
[1]. The Sterile-alpha-motif (SAM) domain is another commonly
occurring motif, facilitating diverse interactions including protein
homo-dimerization, hetero-dimerization, and even RNA binding
[2,3]. Defects in the SAM domains of proteins have been observed
in a number of human diseases [2,4–8]. Notably, chromosomal
translocation of the ETS family transcriptional regulator TEL
(translocation Ets leukemia), a SAM-domain containing protein,
has been frequently linked to human leukemias and it is thought
that the diseases arise because SAM-mediated oligomerization
constitutively activates mitogenic proteins [6,9–11]. The impor-
tance of this domain has led to numerous studies determining the
structure and stoichiometry of SAM-domain complexes [2].
Although in vitro SAM domains are capable of forming both
homo- and hetero-oligomers, it remains unclear how SAM
domains mediate protein interactions under in vivo settings, where
most proteins are expressed at levels much lower than those often
used in biochemical and structural analyses.
In yeast, Ste11 and Ste50 are SAM domain-containing signaling
proteins involved in multiple morphogenetic pathways, including
mating, invasive growth, and high-osmolarity response [12–14].
The interaction of these proteins through their SAM domains is
thought to play a role in the delivery of Ste11, a MAP kinase
kinase kinase, to the cell cortex to activate MAP kinase in response
to environmental signals [15,16]. Several groups have employed
structural and biochemical methods to examine homo and hetero
interactions of purified SAM domains of Ste11 and Ste50 in
solution [17–21]. A consensus of their study is that Ste11 SAM
domains form tight homodimers or high-order oligomers, whereas
the Ste50 SAM domain, with a slightly different sequence, is
largely monomeric in solution but can mediate strong hetero-
dimerization with the Ste11 SAM domain [17,18,20,21]. It is
unknown, however, how these domains might be engaged in
hetero or homo-oligomer formation in vivo, in the presence of the
full length proteins expressed at their endogenous levels and in the
presence of additional interacting partners.
Emerging fluorescence-based technologies probe in vivo binding
equilibrium and stoichiometry of protein complexes. Fluorescence
correlation spectroscopy (FCS) and fluorescence cross-correlation
spectroscopy (FCCS) [22–26] are fluctuation techniques that
analyze protein mobility, concentration, and protein-protein
association (Figure 1A, 1B), and have recently been applied to
live yeast cells expressing autofluorescent proteins (AFP) at the
endogenous levels [27,28]. While FCCS measures co-diffusion of
two particles with different fluorescent tags, extraction of binding
stoichiometry is not easily accomplished with this technique. The
photon counting histogram (PCH) and similar techniques, such as
fluorescence intensity distribution analysis (FIDA), are fluctuation
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e1931techniques designed to analyze the oligomeric status of fluorescent
species and have been applied to both in vitro and in vivo systems.
These techniques determine the state of molecular homo-
oligomerization [29–34] (Figure 1C); however, PCH does not
resolve stoichiometry of heterogeneous complexes that result from
dynamic protein interactions between different molecular species.
Two-dimensional PCH (2dPCH), where two different proteins
are tagged with spectrally distinct probes, is a recently developed
technique that can be used for simultaneous measurement of
stoichiometry and interaction [35,36]. In 2dPCH, a two-
dimensional histogram of fluorescence counts in red and green
channels is generated (Figure 1A, 1D) from fluctuation data. The
surface of the two-dimensional histogram can be fit to yield a two-
dimensional map of the brightness in each channel of diffusing
species. For example, a hypothetical monomeric green probe
diffusing alone with a brightness of 3000 counts per second per
molecule would surface in the plot with a brightness in the green
channel without a contribution in the red channel (Figure 1E). A
red probe diffusing with no green particle would likewise only have
a contribution in the red channel. However, if monomeric red and
green probes are co-diffusing, the corresponding two-dimensional
histogram would be best fit by a diffusing species with brightness
contributions in both channels. In this way, both co-diffusion and
stoichiometry of heterogeneous complexes may be observed. As a
new technique, its in vivo applications have been limited to this
point [35]. However, the combination of GFP with the improved
red AFP, mCherry [37,38], and the ease of introducing these tags
to chromosomal loci through homologous recombination in yeast
Figure 1. Fluctuation data can probe protein-protein interactions. A. Example traces of fluctuation data for dual-color experiments. B. Data
can be analyzed by correlation analysis to examine concentration, diffusion, and co-diffusion of red and green particles. C. 1dPCH examines the
distribution of photon events per time interval, and reports concentration and ‘brightness’, or oligomeric status. D. 2dPCH reports simultaneously
concentration, interaction, oligomerization, and binding stoichiometry of heterogeneous complexes. An example two-dimensional PCH histogram is
shown, with frequency versus number of green photons and number of red photons per time bin. E. Example, two-dimensional plot of a fit of
modeled 2dPCH data. If a monomer red or green probe has a brightness of 3000 CPSM, for example, the plot demonstrates points one would expect
to find values for with non-interacting monomeric species, or interacting monomeric species, or interacting dimeric species, as labeled.
doi:10.1371/journal.pone.0001931.g001
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neous protein complexes in live yeast cells.
In this study, we apply 2dPCH, FCCS, and 1d PCH in live
budding yeast cells to examine the interaction between SAM
domain-containing proteins Ste11 and Ste50 and the effect of
mutations in Ste50’s SAM domain on homotypic and heterotypic
protein interactions. The data allows establishment of a dynamic
model depicting homo and hetero-oligomeric complex formation
among these SAM domain proteins, and represents the first
application of 2dPCH to extract stoichiometry of high order
heterogeneous complexes using endogenously expressed proteins
in live cells.
Results
For examining Ste11 and Ste50 interaction, we constructed a
yeast strain expressing Ste11-GFP and Ste50-mCherry from their
respective chromosomal loci (Table 1). Fluorescence cross-
correlation spectroscopy measurements were first performed as
previously described [27] to confirm the expected heterotypic
interaction (Figure 2). All of the fluorescence fluctuation
measurements described in this study were made on the cytosolic
pool by appropriately targeting the laser beam (Figure 2A and
Materials and Methods). As expected, a high degree of cross-
correlation was observed (Figure 2A, 2B), as demonstrated by the
high amplitude of the cross-correlation curve relative to the
autocorrelation curves of the individual channels. Results were
quantified [39] and showed over 60% of Ste50 bound with Ste11
(Figure 2B). The interaction of these proteins remained strong
after activation of the pheromone response pathway or the osmotic
stress pathway (Figure 2B) (see Materials and Methods). To test if
the observed interaction relies on the SAM domain, two
mutations, L73A and L75A, were introduced into the Ste50
SAM domain (Table 1). These mutations were previously shown
to abolish the binding between Ste11 and Ste50 SAM domains in
vitro [17]. Ste50
L73A-L75A-GFP was driven by the STE50 promoter
from a centromeric plasmid and expressed in the ste50D
background. The cross correlation was diminished (Figure 2A,
2B), demonstrating as expected that the Ste50 SAM domain plays
a role in Ste50’s interaction with Ste11 in vivo.
In vitro, the Ste11 and Ste50 SAM domains have been shown to
mediate homo-oligomerization, but this has not been demonstrat-
ed in vivo when proteins are expressed at the endogenous levels.
Table 1. Yeast strains used in this study.
Strain Genotype Source
rly [27]
2667 MATA BAT2-GFP-mCherry::URA3 (6 Ala linker) [27]
2748 MATA pBZZ1::GFP:HIS5 [27]
3118 MATA ;STE11-GFP::HIS5 [27]
3120 MATA ;STE50-GFP::HIS5 this study
3126 MATA pBZZ1::GFP-GFP-GFP:URA3 [27]
3165 MATA pBZZ1::GFP-GFP:URA3 [27]
3232 MATA ;STE11-GFP::HIS5 STE50mCherry::URA3 this study
3282
MATA ;ste50D; STE11-GFP::URA3;C E NHIS5 plSTE50
L73AL75A-
mCherry this study
3283 MATA ;ste50D;C E NHIS5 plSTE50
L73AL75A-GFP this study
3291 MATA ;pBZZ1::GFP:HIS5 pBAT2::mCHERRY::URA3 this study
3489 MATA pBZZ1::mCherry-mCherry::URA3 this study
all strains are S288C background, his3D1;leu2D0;met15D0;ura3D0.
doi:10.1371/journal.pone.0001931.t001
Figure 2. Cross-correlation analysis determines protein co-diffusion. A. Autocorrelation and cross-correlation curves of Ste11-GFP and
Ste50-mCherry and Ste11-GFP and Ste50-
L73A-L75A-mCherry. Curves are the averages of multiple cells. B. Results for G1 cycling cells, and cells upon
pheromone or osmotic stress pathway activation in live yeast cells (see Materials and Methods). Results were quantified as previously described, as
the percentage of bound particles relative to total [27,39].
doi:10.1371/journal.pone.0001931.g002
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from a small confocal volume to calculate particle concentration
and brightness, usually reported as the average number of
molecules in the focal volume (N) and counts per second per
molecule (CPSM), respectively (Figure 1C) [29,40]. As a
comparison technique, molecular brightness reflects the oligomeric
state of the fluorescent species when compared to the brightness of
a standard, for example, a known monomer or dimer of the same
fluorescent molecule. For controls, yeast strains expressing
monomeric, dimeric, and trimeric cytosolic GFP under the control
of the BZZ1 promoter were constructed, as previously described
(Table 1) [27]. The distribution of brightness values for 1dPCH
measurements in live yeast cells were recorded using the Zeiss
confocor 3 with 488 nm excitation and BP 505–540 nm emission
collection (Materials and Methods). Box plots, as well as example
curves, are shown in Figure 3A and 3B. The brightness
distributions of these GFP species were easily distinguishable,
providing the basis of comparison for oligomeric status of mobile
GFP-tagged proteins in yeast. In addition, the BAT2 locus was
replaced by cytosolic mCherry and the BZZ1 locus was replaced
by mCherry-mCherry (Table 1). At the low excitation powers that
are necessary to minimize photobleaching in our experiments, the
brightness of mCherry was less than that of eGFP (Figure 3B) but,
at over 2000 CPSM, still presented an improvement from other
monomeric, red autofluorescent protein options [35], as expected
based on improvements in photostability, and quantum yield
[37,38].
Box plots of average brightness for individual 1dPCH
measurements of Ste11 and Ste50 are presented in Figure 3C,
with lines representing average brightness values of monomer,
dimer, and trimer controls for a basis of comparison. Ste11
exhibited an average brightness close to that of dimeric cytosolic
GFP, whereas Ste50 showed an average brightness in-between
dimeric and trimeric cytosolic GFP. Interestingly, the SAM
domain mutant, Ste50
L73A-L75A-GFP, revealed a brightness much
reduced relative to Ste50-GFP, near that of monomeric GFP,
suggesting that these mutations also affect homo-oligomerization
of Ste50. Surprisingly, PCH of Ste11-GFP in a yeast strain where
the only form of Ste50 was untagged Ste50
L73A-L75A revealed a
decreased brightness, distinct from the distribution of Ste11-GFP
in wild-type cells (p,0.05), suggesting that the SAM domain of
Ste50 is also required for stabilization of Ste11 homo-oligomers.
To examine the effect of signals that normally activate MAP
kinase cascade on Ste11-GFP and Ste50-GFP complexes, we
activated the yeast mating response pathway by treatment of yeast
cells with 50 mM a-factor or the osmotic stress pathway by treating
the cells with 0.4 mM NaCl for 30 minutes [14] (see Materials and
Methods). Average brightness values for PCH measurements are
shown in Figure 3C. The average brightness of Ste11-GFP and
Ste50-GFP were slightly decreased in response to both conditions.
The average brightness values of Ste11-GFP and Ste50-GFP,
which were above the brightness of monomeric GFP, suggested an
ability of these proteins to form homo-oligomeric structures, but
the composition of the complexes was unclear. This represents a
Figure 3. 1dPCH analysis of Ste50-GFP and Ste11-GFP probes homo-oligomerization. A. Example curves for GFP and mCherry (mCH.)
controls in live yeast. B. Notched box plots of PCH fits, ranging from 18 to 30 individual, 7 second data traces from 5 to 10 cells. For auto-fluorescence
measurements, data represents 7 measurements for mCherry and 15 measurements for GFP. 50 ms bins were used to generate the PCH distributions.
C. Notched box plots of 1dPCH fits of GFP tagged species, with lines (same color scheme as in B) representing average brightness values of
monomer, dimer, and trimer controls for a basis of comparison.
doi:10.1371/journal.pone.0001931.g003
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Ste50-GFP could be explained by a distribution of dimers and
trimers, but could also be explained by a distribution of monomers
and high-order oligomers, or any other combination. In an ideal
case, such as a solution measurement, sufficient statistics can be
obtained to accurately distinguish a distribution of species freely
from PCH data without a priori knowledge. However, this is not
the case in live yeast cells due to limits of laser exposure time to
minimize photobleaching. Similarly, other live cell studies have
also found it necessary to make certain reasonable assumptions
and/or fix brightness values to fit fluctuation data to distributions
to extract additional information [32,40].
To better examine the stoichiometry of the Ste11 and Ste50
complexes, 2dPCH was performed. As a proof of principle, we first
applied 2dPCH to a yeast strain expressing GFP and mCherry
physically linked to the cytosolic protein Bat2 [27] (Table 1). The
2dPCH histograms of Bat2-GFP-mCherry fit well to a 1 species
model, with diffusing particles having coincidence brightness in the
GFP and mCherry channels with values consistent with mono-
meric GFP and mCherry (Figure 4, compare to Figure 3B). As a
negative control, 2dPCH was conducted for a yeast strain
expressing unlinked, cytosolic GFP and cytosolic mCherry
(Table 1). As expected, the data fit well with a two-species model
(average chi
2=0.9) but not with a one-specie model (average
chi
2=4.5). The resulting brightness values for the 2dPCH data
sets were consistent with those expected for monomeric GFP and
mCherry. In all two-species 2dPCH fits, an F test was used to
validate the necessity of the second-component (F.97%).
2dPCH was applied to the Ste11-GFP, Ste50-mCherry
fluctuation data, and revealed the in vivo binding stoichiometry
of the complexes (Figure 4). Again, a one-specie model did not
adequately fit the data (average chi
2=4.1); a two-component fit
was necessary (average chi
2=1.2). The data reveal a dominant
specie (N comprises approximately 65 to 75% of the total particles
from the fit) with a mCherry average brightness (24006150)
consistent with that of a monomer (p=0.12) and a GFP average
brightness of 49806230, which is indistinguishable from the
1dPCH GFP-GFP dimer brightness (p=0.7). Thus, the data
suggests a dominant complex in the yeast cytosol consisting of
monomeric Ste50 and dimeric Ste11. A second abundant specie
revealed by the 2dPCH consisted of a high order oligomer of
Ste50 that is not associated with Ste11. This data reveals a mutual
exclusiveness between Ste50 homo-oligomerization and Ste50
forming a complex that contains two molecules of Ste11. Based on
1dPCH data, we expected a small fraction of a third specie,
consisting of monomeric Ste11, but a three-component fit cannot
be confirmed with statistics provided by the live cell measure-
ments. Consistent with the lack of cross-correlation reported in
Figure 2, 2dPCH of Ste11-GFP, Ste50
L73A-L75A-mCherry did not
fit with a one-specie model (average chi
2=6.8), but rather a two-
species model (average chi
2=1.2), with non-interacting, mono-
meric species. This result confirms the FCCS and 1dPCH results
that the Ste50 SAM domain is required for homo-oligomerization
of Ste50, interaction of Ste50 with Ste11, and it plays a role in
stabilization of the Ste11 dimer.
The effects of activation of the mating pathway and osmotic
stress pathway were subtle, with the dominant specie in either case
still consisting of monomeric Ste50 interacting with Ste11. The
average GFP brightness value of this dominant complex under
these conditions were lower than that in cycling cells; this decrease
was statistically significant at the 95% level for high salt conditions
relative to wt (p=0.05) but not at the 95% confidence limit for a-
factor treated cells (p=0.11). The trend is consistent with a lower
average brightness of the Ste11 component of this complex, and
perhaps a distribution of interacting species that varies between
2:1 and 1:1 Ste11:Ste50. The average brightness of the Ste50 high-
order oligomer observed by 2dPCH was significantly reduced
upon activation of the pheromone pathway (p=0.02), while the
average brightness of the oligomer upon activation of the osmotic
stress pathway was not reduced at a statistically high confidence
level (p=0.24).
Thus, a possible effect of activation of these pathways is a trend
toward a reduction in the size of the high-order Ste50 oligomer.
This is consistent with change observed by 1dPCH as the
decreased average brightness of Ste50-GFP upon activation of
the signaling pathways. However, at this point we are uncertain
Figure 4. 2dPCH analysis of Ste50-mCherry and Ste11-GFP detects binding stoichiometry. 50 ms bins were used. Data were fit to a one-
component model or two-component model, as explained in the text. Symbols and bars represent the averages and standard deviations,
respectively. Schematic representations of average stoichiometry observed; possible geometries of the interactions (see main text) are displayed next
to the corresponding regions of the graph.
doi:10.1371/journal.pone.0001931.g004
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number of mCherry subunits at high stoichiometry. The
brightness of GFP complexes scales well with GFP subunits, as
demonstrated by the fit of the average brightness of the
monomeric, dimer, and trimeric controls (Figure 5). We revisited
the 1dPCH data of Ste50-GFP to attempt to better quantify the
stoichiometry of the high-order, Ste50 oligomer. The result that
the dominant specie of Ste50 was a monomer, as shown by
2dPCH, provided an important constraint for fitting the 1dPCH
data to a distribution. Therefore the 1dPCH data for Ste50-GFP
was fit to a distribution consisting of a fixed monomer brightness
and freely varied oligomer brightness. N for each species was also
freely varied. The Ste50 1dPCH data was well fit (average
chi
2=0.9) to a distribution that consists of a large percentage of
monomer and a small percentage of high order oligomer, in
percentages roughly equivalent with those found using 2dPCH.
The constrained fits revealed that the treatment with a-factor or
high salt led to a slightly decreased percentage of oligomer, and
also a decreased oligomer brightness (Figure 5). Using this
analysis, average brightness values of the Ste50 oligomer were
approximately 12,500, 8900, and 7700 CPSM for cycling cells, a-
factor treated cells, and cells at high salt, respectively (Figure 5).
Assuming that the linearity of GFP brightness continues to hold
at a high number of subunits, we estimate the number of Ste50
subunits in this complex to be ,5 to 6 in cycling cells, ,4i na-
factor treated cells, and ,3 to 4 in high salt condition. While the
slight decrease in brightness of the Ste50 oligomer was also
observed with mCherry in the 2dPCH data, it was not nearly as
pronounced as that observed with 1dPCH (Figure 3D) or the
global fit (Figure 5), raising the possibility that mCherry
brightness may not scale linearly with subunit number at high
stoichiometry, perhaps due to a self-quenching mechanism or
increased propensity for photobleaching or photoblinking relative
to GFP.
Discussion
The analyses presented above demonstrate that whereas FCCS
and 1dPCH provide valuable information on the strength of the
interaction between two molecular species and average oligomer-
ization status of individual molecular species, respectively, 2dPCH
is better suited for revealing the binding stoichiometry of protein
complexes in vivo. Specifically in this study, 2dPCH revealed a
predominant complex of Ste11 and Ste50 with a 2:1 binding
stoichiometry, and a pool of large, Ste11-free Ste50 oligomers.
The heterotypic complex is consistent with previous biochemical
data [17,18,21]. However, the requirement of Ste50 SAM domain
for the integrity of this complex in vivo suggests that either Ste11
molecules in this complex do not directly dimerize through their
SAM domains but rather they each bind a common Ste50 SAM
domain at two different surfaces (Figure 4); or, a strong direct
interaction between two Ste11 molecules is stabilized by the Ste50
SAM domain. The former possibility is supported by the structural
study demonstrating that Ste50 binds Ste11 in a head to tail
fashion [19], which could also explain the ability of Ste50 to form
homo-oligomers (Figure 4). The most unexpected finding was the
presence of large Ste50, but not Ste11, homo-oligomers, because in
vitro the Ste11 SAM domain, but not the Ste50 SAM domain, has
the strong propensity to form oligomers [2,6,20,21]. Even though
we do not have an explanation for the difference between the in
vivo and in vitro observations, this result highlights the need to
directly probe protein complex stoichiometry using techniques
such as 2dPCH in live-cell settings.
The SAM domain-mediated interaction between Ste50 and
Ste11 is known to be important for efficient MAP kinase signaling
Figure 5. Constrained fits of the 1dPCH data to two-species allows for the examination of monomer and oligomer populations. A. A
model was assumed where Ste50 could exist as either a monomer with fixed brightness, or oligomer with unconstrained brightness and number (see
Materials and Methods, and main text). Results are displayed to show the percentage of each component. Error bars are the standard error of the
mean. B. Average brightness values for autofluorescence, GFP, GFP-GFP, and GFP-GFP-GFP from the data in Figure 3, fit to a line. Error bars are the
standard deviation. The line represents the best fit of the data to a linear model with a slope of 1959 and intercept 1193, which was then extrapolated
toward higher brightness. Average brightness observed for the Ste50 oligomer from the analysis described above are marked on the extrapolated
part of the plot.
doi:10.1371/journal.pone.0001931.g005
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that this interaction facilitates the targeting of Ste11 to the site of
receptor signaling at the plasma membrane where Ste20, the
upstream kinase for Ste11, is activated by the small GTPase Cdc42
[12,14,15,41] Ste50 itself is recruited to the membrane through an
interaction of the C-terminal RA domain with Cdc42 [16]. An
ability of one Ste50 to simultaneously bring two molecules of Ste11
to the site of active Ste20 on the cortex may significantly enhance
the efficiency of Ste11 phosphorylation by Ste20, while the large
Ste50 homo-oligomers may be a dynamic reservoir for Ste50 that
could buffer the concentration of Ste50 monomers available for
interaction with Ste11. A recent study showed that the mobile
Ste11 concentration increases following pheromone stimulation
[27], and this would be consistent with a need to mobilize some of
the Ste50 reserved in the homo-oligomers to the monomer pool,
leading to the reduced average size of the Ste50 oligomer.
The homo-oligomers of Ste50 observed in yeast may be similar
to the high affinity, high-order oligomers proteins observed for
SAM domains from proteins such as translocation ETS leukemia
(TEL) or Eph receptor tyrosine kinase (EphB2) [6,42]. As
mentioned above, the constrained two-component fit of the
1dPCH data for Ste50-GFP reported a stoichiometry of the Ste50-
oligomer in cycling cells of 5 to 6 subunits. Given the caveat that
the brightness of GFP might not rise linearly with high-order
oligomers, it is still intriguing that the estimated stoichiometry of
Ste50 in vivo compares well to the stoichiometry proposed for
oligomers of TEL or EphB2 [2,6,42]. While these models
generally predict a linear or head-to-tail model, if this applies to
the Ste50 oligomer it would be difficult to explain the observed
lack of binding to Ste11. One possibility is that formation of the
Ste50 oligomer induces a conformational change in the Ste50
SAM domain that makes binding to Ste11 less likely, as depicted in
Figure 4. It may be interesting to test if the TEL SAM domain
homo-oligomers, which are thought to account for certain types of
human leukemia [2,6,9–11], also modulate the interaction with
other regulatory molecules and respond dynamically to morpho-
genetic signals.
Materials and Methods
Yeast culture
One-step COOH-terminus genomic tagging was used for
generating yeast strains expressing both GFP and mCherry
labeled genes [43,44] unless otherwise specified. Correct tagging
was verified by PCR. For correlation analysis, yeast cells were
grown in synthetic complete media to mid-log phase. For
examination of Ste50 SAM mutants, Ste50-GFP or Ste50-
mCherry was subcloned into a centromeric plasmid, with its
promoter region. Mutations were made and verified with
sequencing. The centromeric plasmids were transformed into
Dste50 strains for analysis. For examination of the mating pathway,
pheromone (a-factor) was incubated with yeast at a concentration
of 50 mM for 2 hours. For activation of the HOG pathway, yeast
cells were treated with 0.4 mM NaCl for 30 minutes as described
[14]. Yeast cells were immobilized on glass for analysis.
FCS
The experimental set-up for FCS, FCCS, and 1dPCH was used
as previously described [27]. Briefly, for cross-correlation studies,
the 488 nm and 561 nm laser lines were used with the HFT 488/
561 dichroic to excite GFP and mCherry, respectively. Emission
was split with an HFT565 dichroic, and a 505–540 BP emission
filter was used for the green emission channel and a LP 580 nm
filter for the red channel. The pinhole was set to 1.0 airy unit in
the red channel. Autocorrelation curves for the individual
channels and a cross-correlation curve between the channels was
calculated by the Zeiss Confocor-3 software according to
equations 1 and 2, respectively:
Gac t ðÞ ~
SdFt ðÞ :dFt zt ðÞ T
SFt ðÞ T
2 ð1Þ
Gcc t ðÞ ~
SdP1 t ðÞ :dP2 tzt ðÞ T
SP1 t ðÞ P2 t ðÞ T
ð2Þ
where dF(t)=F(t)2ÆFæ and P1 and P2 represent photon counts in
channel 1 and 2, respectively.
For cross-correlation experiments, the number of bound
particles was calculated from Eq. 3 [39], where the inverse
amplitude of the autocorrelation curves was used to calculate the
number of red (NRT) or green particles (NGT) (Eq. 4). Ncc is the
inverse amplitude of the cross-correlation curve, and the cross-talk
between channels, Q, was estimated to be approximately 5% for
the GFP and mCherry probes using the filter sets described above.
This is discussed in more detail elsewhere [27]. A volume
correction was applied to take into account small differences in
red, green, and cross-correlation volumes [45].
Nbound~
NGT NRTzQ:NGT ðÞ
Ncc
{NGT:Q ð3Þ
N~c= G0{1 ðÞ : ð4Þ
PCH
1dPCH was conducted as previously described [27]. The
488 nm laser line was used with a HFT 488/561 main dichroic,
an HFT565 secondary emission dichroic, and a 505–540 BP
emission filter. Fluorescence traces were collected in 7 second
increments, and 4 to 5 measurements were collected per cell.
Data was arranged as a histogram of number of photon events
p e ru n i tt i m eu s i n gab i nt i m eo f5 0ms. Data was fit with the
PCH algorithm [29,30] to extract an average brightness and
particle number per measurement. A 3-dimensional Gaussian
focal volume (1-photon) was used. Control strains expressing
GFP, GFP-GFP and GFP-GFP-GFP linked proteins (under the
BZZ1 promoter) were used for monomer, dimer, and trimer
brightness controls (Table 1). Importantly, to verify the reliability
of 1-photon PCH in live yeast, the brightness values for the
control strains were linearly spaced, taking auto-fluorescence
into account.
For 2dPCH [35,36], the experimental set-up was identical to
the cross-correlation set-up described above and previously [27].
Data were taken in ten-second increments, and arranged in a
two-dimensional histogram of counts in each channel as a
function of frequency for 50 ms bins. Data were fit to one or two
components, and brightness values and particle number in each
channel were allowed to freely vary. An F-test was used to
validate the necessity of two-component fits (F.97%). The plots
in Figure 4 represent averages and standard deviations for N
between 6 and 15 cells.
For fitting Ste50-GFP, 1dPCH data to a two-component model,
as shown in Figure 5, the brightness of a mono-
mer specie was fixed. The number of monomer, brightness of
oligomer, and number of oligomer were freely varied.
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